Microbiome therapeutic beats placebo for recurrent C. difficile
(HealthDay)—An investigational microbiome therapeutic composed of purified Firmicutes spores, SER-109, is superior to placebo for treatment of recurrent Clostridioides difficile infection, according t
Updated on: May 17,2024
3

Microbiome therapeutic beats placebo for recurrent C. difficile
(HealthDay)—An investigational microbiome therapeutic composed of purified Firmicutes spores, SER-109, is superior to placebo for treatment of recurrent Clostridioides difficile infection, according t
Updated on:May 17,2024
3
